Mohammad-Reza Ardalan
1*1 Chronic Kidney Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Implication for health policy/practice/research/medical education:
An inhibitor of the mammalian target of sirolimus (mTOR) is used as an agent for immunosuppression of solid organ transplantation. Its advantages include lack of nephrotoxicity and a lower incidence of post-transplant cancers and thrombotic microangiopathy. Delayed wound healing, proteinuria and pulmonary infiltration are reported complications of sirolimus.
Please cite this paper as: Ardalan MR. Lymphedema attributed to sirolimus. J Nephropharmacol 2013; 2(2): 35-36.